Stanley Zimmerman, MD
Interventional Cardiology · Tulsa, OKNPI 1861614737
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $59,600 of the $93,164 with a category attached, or 64.0%. Penumbra, Inc. accounts for 85.5% of it on its own, with 33 other manufacturers making up the rest. 2025 is the largest year on record at $43,736, 7.1 times the $6,144 reported in 2019. Among interventional cardiology clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 230 payments — averaging $405.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$80K
- Medtronic$7K
- Abbott$2K
- Shockwave Medical, Inc$1K
- Abiomed$1K
- Angiodynamics, Inc.$248
- plus $2K from 28 others
Across 2 payments — averaging $4664.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Penumbra, Inc.$9K
What the payments were for
- Consulting fees$3,4574%
- Speaking & faculty fees$59,60064%
- Travel & lodging$19,16821%
- Food & beverage$10,93212%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 97 | $79,621 |
| Medtronic(2 entities) | 24 | $6,788 |
| Abbott | 18 | $2,416 |
| Shockwave Medical, Inc | 4 | $1,126 |
| Abiomed | 14 | $1,019 |
| Angiodynamics, Inc. | 8 | $248 |
| Inari Medical, Inc. | 4 | $233 |
| Surmodics, Inc. | 2 | $209 |
| Reflow Medical Inc | 1 | $200 |
| Bard Peripheral Vascular, Inc. | 1 | $157 |
| Pfizer | 9 | $144 |
| Philips North America LLC | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 7 | $117 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $110 |
| Inspire Medical Systems, Inc. | 3 | $85 |
| Amgen | 5 | $67 |
| Kestra Medical Technology Services, Inc. | 2 | $54 |
| Novartis | 3 | $49 |
| Cardiva Medical, Inc. | 1 | $49 |
| Imperative Care, Inc | 2 | $45 |
| Boston Scientific | 1 | $38 |
| Terumo Medical Corporation | 2 | $34 |
| Actelion Pharmaceuticals US, Inc. | 2 | $32 |
| Atricure, Inc. | 1 | $32 |
| Teleflex LLC | 2 | $26 |
| Cathworks, Inc. | 1 | $26 |
| Getinge USA Sales, LLC | 1 | $22 |
| Edwards Lifesciences | 1 | $18 |
| Bayer | 1 | $16 |
| Stryker | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| AstraZeneca | 1 | $12 |
| Cardiovascular Systems Inc. | 1 | $12 |
| BTG International Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$77,456
- HawkOne$4,414
- CardioMEMS HF System$2,007
- Penumbra System$1,395
- FlowMet-R$1,202
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$800
- Resolute$745
- Impella$424
- Vascular Lithotripsy$326
- Pounce Thrombectomy System$193
- Pounce Venous Thrombectomy System$193
- Sublime 014 Rx PTA Balloon Dilatation Catheter$193
- Sublime Radial Access 018 RX PTA Dilatation Catheter$193
- Sublime Radial Access Guide Sheath$193
- FLOWTRIEVER CATHETER, S$191
- CT THROMBECTOMY SYSTEM KIT$191
- VenaSeal$180
- Venclose Maven Catheter$157
- Accent Pacemaker$144
- (4067) Tack Endovascular Systems BTK$125
How this compares
$93,164 in reported general payments places this provider in the 95th percentile of 110 interventional cardiology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 123 | $134,193 |
| EntrestoSacubitril/Valsartan | 46 | $64,535 |
| Repatha SureclickEvolocumab | 81 | $63,340 |
| XareltoRivaroxaban | 44 | $49,167 |
| BrilintaTicagrelor | 44 | $23,400 |
| Repatha SyringeEvolocumab | 23 | $14,961 |
| Atorvastatin Calcium | 185 | $2,478 |
| Rosuvastatin Calcium | 101 | $2,129 |
| ClopidogrelClopidogrel Bisulfate | 255 | $2,125 |
| Metoprolol Succinate | 120 | $1,651 |
| Carvedilol | 210 | $1,345 |
| Losartan Potassium | 62 | $799 |
| Midodrine Hcl | 12 | $742 |
| Ezetimibe | 22 | $476 |
| Lisinopril | 69 | $458 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $144 | $134,193123 claims |
| NovartisEntresto | $49 | $64,53546 claims |
| Johnson & JohnsonXarelto | $13 | $49,16744 claims |
| AstraZenecaBrilinta | $12 | $23,40044 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 110 interventional cardiology providers in Oklahoma.
Other interventional cardiology in Tulsa
- Kamran MuhammadTulsa$1.4M
- Matthew ComstockTulsa$69K
- Wayne LeimbachTulsa$68K
- Tom HuTulsa$57K
- Eugene IchinoseTulsa$49K
- Poorya FazelTulsa$29K
- Tucker HarrisonTulsa$19K
- Andrew KurklinskyTulsa$15K
- Stewart KatzTulsa$13K
- Arash KarnamaTulsa$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.